|
| Pivot Bio, a synthetic biology company working on nitrogen-producing microbes, announced yesterday that it has completed a Series B round of financing totaling $70 million led by Bill Gates’ innovation investment fund, Breakthrough Ventures.
Breakthrough Ventures is a $1 billion fund with famous investors like Gates and other high-profile billionaires like Jeff Bezos and Richard Branson. The fund focuses on innovation aimed at addressing different areas of environmental concern, with recent investments in a company working to decrease carbon in the concrete industry, a group working on a nuclear-fusion reactor that could produce net-positive energy and, in the agriculture space, the investment in Pivot.
70 billion and no real good data proving Pivot Bio works? I hope the other projects in Breakthrough Ventures turn out better. | |
|